Increasing regulatory approvals for intravenous solution injections are expected to drive the global Intravenous Solutions Market growth over the forecast period. For example, in 2015, B. Braun Medical Inc, a subsidiary of B. Braun that specialises in infusion therapy and pain management, announced that its 70 percent Dextrose for Injection in a 2L flexible container had received FDA approval in the United States. 70 percent Dextrose for Injection is an intravenous solution used to replenish calories and fluids. The introduction of new intravenous solution injections for the treatment of various diseases such as dehydration and gastrointestinal diseases is expected to drive intravenous solution market growth during the forecast period.
Read More@ https://bit.ly/31tJNwK
